Invention Grant
- Patent Title: Method for differentially diagnosing ACTH-dependent cushing's syndrome
-
Application No.: US15796443Application Date: 2017-10-27
-
Publication No.: US10006924B2Publication Date: 2018-06-26
- Inventor: Andreas G. Moraitis
- Applicant: Corcept Therapeutics, Inc.
- Applicant Address: US CA Menlo Park
- Assignee: Corcept Therapeutics, Inc.
- Current Assignee: Corcept Therapeutics, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/74
- IPC: G01N33/74 ; A61K31/567 ; A61K31/573 ; A61K31/4745

Abstract:
This invention provides for an improved method for differentially diagnosing ACTH-dependent Cushing's syndrome. Current practice for differentially diagnosing ectopic ACTH syndrome and Cushing's Disease measures relative ACTH concentrations from the inferior petrosal venous sinus compared to fluid obtained from a periphery venous sample. This is performed before and after administration of exogenous corticotropin releasing factor, or after administration of metyrapone. This invention uses glucocorticoid receptor antagonists to induce release of endogenous CRH which stimulates ACTH to increase in patients with ectopic ACTH syndrome but not in those with Cushing's Disease.
Public/Granted literature
- US20180052178A1 METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME Public/Granted day:2018-02-22
Information query
IPC分类: